Full Library

Solid organ and hematopoietic stem cell transplant recipients are at high risk of contracting infectious diseases, including vaccine-preventable illnesses, in the post-transplant period. Given the high degree of immunosuppression immediately post-transplant, infection in the transplant patient results in higher morbidity and mortality than in the general population. Thus, it is the responsibility of the care team to ensure appropriate vaccines are given in an attempt to mitigate this risk. Timing of vaccination in the solid organ or hematopoietic stem cell transplant recipient is critical in order to strike a balance between providing protection against vaccine-preventable illnesses as early as possible, and vaccinating at a time when it is safe and the host’s immune response to vaccination will be adequate. This chapter will focus on providing a rationale for and summary of the specific recommendations pertaining to vaccination of both the solid organ and hematopoietic stem cell transplant recipient.

DOI: 10.1007/978-3-030-01751-4_11-1